rs1061170, CFH

N. diseases: 72
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Two variants in the complement factor H (CFH) gene, Y402H and I62V, are strongly associated with risk of AMD. 27647805 2017
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Complement factor H polymorphism in exon 9 (Y402H) has shown a strong association with susceptibility to AMD resulting in complement activation, recruitment of phagocytes, RPE damage, and visual decline. 28913923 2017
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE CFH Y402H SNP might be protective for AMD in the Turkish population. 27404493 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE The polymorphism rs1061170/Y402H might be a genetic predictor of treatment response to anti-VEGF therapy in AMD patients. 27151934 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Odds ratios, especially for the main risk polymorphisms in ARMS2 (rs10490924) and CFH (rs1061170), gained with increasing disease severity and bilateralism (exemplarily: rs1061170: unilateral early AMD: OR = 1.18; bilateral early AMD: OR = 1.20; unilateral intermediate AMD: OR = 1.28; bilateral intermediate AMD: OR = 1.39, unilateral geographic atrophy (GA): OR = 1.50; bilateral GA: OR = 1.71). 27257685 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis. 27269047 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE To evaluate the association of extramacular drusen (EMD) with age-related macular degeneration (AMD) and with complement factor H (CFH rs1061170) and age-related maculopathy susceptibility 2 (ARMS2 rs10490924) polymorphisms in individuals with and without AMD. 26614632 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Based on this, we conclude that liver-kidney yin-deficiency AMD is associated with the C allele and TC and CC genotypes of the CFH Y402H polymorphism. 27706724 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE AMD individuals who had at least one copy of the C allele of rs1061170 had an increased risk of disease compared with cases with the T allele. 25612476 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE AG genotype of CCL2-2518 in combination with TT genotype of CFH Y402H showed significant protective effect against AMD. 27316788 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE This meta-analysis suggested that CFH rs1061170 and rs1410996 polymorphisms were associated with AMD risk, both of which demonstrated a higher susceptibility to AMD, especially to nAMD. 26727378 2016
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE These results suggest that a genetic predisposition to AMD conferred by the CFH Y402H variant limits the benefit provided by DHA supplementation. 26132079 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Homozygous carriers of the Y402H risk variant in the complement factor H (CFH) gene developed neovascular AMD 2.8 (95% CI, 0.5-5.0) years earlier (P = .02). 25695752 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE No associations appeared between HIF1A SNPs and AMD, which were studied here for the first time; however, polymorphism rs1061170 of the CFH gene is associated with AMD in our population. 24995509 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Risk alleles of three SNPs, rs1061170 (CFH), rs1410996 (CFH), and rs10490924 (ARMS2) were found to be significantly associated with the AMD case/control status as defined by the algorithm. 26255974 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE To determine age-related macular degeneration (AMD) phenotypes associated with mutually exclusive homozygotic risk variants in rs1061170 (CFH) and rs11200638 (HTRA1). 25627090 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Female sex and the presence of both risk alleles of CFH-rs1061170 or ARMS2-rs10490924 were independently associated with early AMD incidence, whereas current smoking and presence of ≥1 risk allele of CFH-rs1061170 or ARMS2-rs10490924 were associated with late AMD incidence. 26383995 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE The present study confirmed the association between CFH Y402H SNP and wet AMD in the Greek population (OR=1.77, p=0.002). 25811666 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Younger age of exudative AMD onset was associated with the homozygous AA genotype of IL-8 rs4073 (p = 0.009, Mann-Whitney U-test), CC genotype of CFH rs1061170 (p = 0.016), TT genotype of ARMS2 rs10490924 (p = 0.001) and with current smoking (p = 0.002). 26154559 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE In conclusion, pharmacogenetics of CFH Y402H polymorphism may play a role in response to anti-VEGF treatment for neovascular AMD, especially for Caucasians. 26411831 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE This study found significant association of SNPs rs529825, rs800292, rs203674 and rs1061170 in the CFH gene with susceptibility to AMD. 26152901 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE After adjusting for CFH Y402H genotype, age, sex and smoking history, the level of sTNFRII remained a significant predictor for prevalence of AMD with odds ratios at 3.0 in the middle and 3.6 in the highest tertiles. 25363549 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE A 6.7-fold increased odds of AMD (95% CI, 1.6-28.2) was observed among women with deficient vitamin D status (25[OH]D <12 ng/mL) and 2 risk alleles for CFH Y402H (SI for additive interaction, 1.4; 95% CI, 1.1-1.7; P for multiplicative interaction = .25). 26312598 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE Our results revealed that CFH polymorphisms I62V and Y402H might be associated with the susceptibility to AMD in Chinese population. 26045838 2015
Age related macular degeneration
CUI: C0242383
Disease: Age related macular degeneration
0.900 GeneticVariation BEFREE In contrast, among pseudophakic/aphakic individuals, the CFH Y402H risk genotypes were significantly associated with higher odds of early AMD, with an OR of 1.57 (95% CI: 1.07-2.29) for GA genotype and 2.40 (95% CI: 1.25-4.61) for AA genotype, compared to those with GG genotype. 25786237 2015